Novel Antibiotic Nanosphere
This technology uses biodegradable nanospheres to deliver vancomycin locally at surgical sites, providing sustained antibiotic release for about a month to prevent infections, improve healing, and reduce side effects, with potential for other drug deliveries.
The Problem
Current local antibiotic delivery methods, such as antibiotic-loaded bone cement or hydrogels, face significant limitations. Hydrophilic antibiotics like vancomycin are notoriously difficult to encapsulate efficiently within hydrophobic biodegradable polymers, resulting in poor drug loading (often less than 30%) and rapid, uncontrolled release—typically lasting less than a week. This short release window does not align with the typical post-operative healing period, which can extend several weeks, thus failing to maintain protective drug concentrations when they are most needed. Furthermore, many existing delivery vehicles are not fully biodegradable, potentially necessitating additional surgical intervention for removal and increasing the risk of complications. These challenges highlight the urgent need for improved local delivery systems capable of providing high, sustained antibiotic concentrations at the surgical site over clinically relevant timeframes.
The Solution
This technology is a biodegradable nanosphere system engineered for the sustained, localized delivery of vancomycin to prevent surgical site infections, especially in high-risk, implant-based procedures. By forming a hydrophobic ion pairing (HIP) complex with vancomycin and encapsulating it within biodegradable polymers such as PLGA, PLA, and PCL, the system achieves high drug loading and a controlled release profile. The HIP complex significantly increases vancomycin’s lipophilicity, allowing efficient encapsulation within the hydrophobic polymer matrix. The nanospheres are fully biodegradable, ensuring they dissolve naturally in the body without requiring surgical removal. Experimental results show over 90% HIP formation efficiency, a 100-fold increase in hydrophobicity, high encapsulation efficiency, and sustained antibiotic release above therapeutic levels for more than 28 days, effectively covering the critical post-operative healing period.
The Opportunity
This solution is differentiated by its ability to overcome the traditional challenges of encapsulating hydrophilic, zwitterionic antibiotics like vancomycin in hydrophobic biodegradable polymers—a feat that previously resulted in poor drug loading and short, uncontrolled release durations. The innovative application of HIP chemistry to vancomycin, combined with tunable biodegradable polymer matrices, enables a clinically relevant, month-long release that matches the wound healing timeline and maintains effective local drug concentrations.
